Core Insights - The Chemours Company (CC) has updated its second-quarter 2025 outlook, expecting consolidated net sales to be at the high end of the original range with a sequential mid-teens increase [1] Segment Performance - The Thermal & Specialized Solutions (TSS) segment anticipates a sequential net sales increase of around 25% due to stronger demand for Opteon Refrigerants, with an expected sequential adjusted EBITDA increase of roughly 40% [2] - In contrast, the Titanium Technologies (TT) segment projects a 15% sequential decline in adjusted EBITDA, attributed to operational disruptions at its U.S. site, resulting in approximately $15 million in incremental costs and other one-time operational disruptions costing around $10 million [3] - The Advanced Performance Materials (APM) segment's net sales are predicted to align with low teens sequential growth expectations, while adjusted EBITDA is expected to increase around 25% sequentially due to stronger overall cost performance [4] Financial Expectations - CC's consolidated adjusted EBITDA is now expected to be in the range of $215 million to $225 million, with positive consolidated free cash flow projected for the second quarter [5][9] - The company has experienced a significant stock decline of 51.5% over the past year, compared to the industry's 24.7% decline [7]

Toronto, Ontario--(Newsfile Corp. - Le 2 juin/June 2025) - Core Assets Corp. has announced a name change to Core Silver Corp. and a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares. As a result, the outstanding shares of the company will be reduced to approximately 12,710,565 common shares. The shares will begin trading on a consolidated basis and with a new name and CUSIP number on June 4, ...

Core Viewpoint - Chemours Company has partnered with DataVolt to develop innovative liquid cooling solutions for data centers, aiming to enhance efficiency and sustainability in response to the growing demand for AI and next-generation chips [1][2][4]. Group 1: Partnership and Technology Development - The collaboration will focus on two-phase direct-to-chip and immersion cooling technologies, leveraging Chemours' ultra-low global warming potential Opteon dielectric fluids [3]. - This partnership aims to accelerate the adoption of liquid cooling technologies, reducing the total cost of ownership and environmental impact while improving performance and efficiency [2][4]. Group 2: Market Context and Financial Outlook - Chemours' shares have decreased by 59.7% over the past year, compared to a 27.2% decline in the industry [5]. - The company anticipates a sequential increase in consolidated net sales in the low to mid-teens for the second quarter, with adjusted EBITDA expected to rise by 40% to 45% [6]. - For the full year 2025, adjusted EBITDA is projected to be between $825 million and $950 million, with capital expenditures estimated at $225 million to $275 million [6].

Core Viewpoint - The Chemours Company reported a net loss of $4 million for Q1 2025, a significant decline from a net income of $54 million in the same quarter last year, indicating challenges in profitability despite a slight increase in net sales [1]. Financial Performance - The company achieved first-quarter net sales of $1,368 million, reflecting a 1.3% increase year-over-year and surpassing the Zacks Consensus Estimate of $1,355.2 million, driven by a 5% increase in volume despite a 4% drop in pricing and a 1% negative currency impact [2]. - Adjusted EBITDA for the quarter declined by 13% year-over-year to $166 million, primarily due to lower pricing across business segments, particularly in Thermal & Specialized Solutions and Titanium Technologies [3]. Segment Highlights - The Titanium Technologies division reported revenues of $597 million, a 1% increase from the previous year, exceeding the estimate of $579.2 million, attributed to a 6% increase in volumes, offset by a 4% decrease in price [3]. - The Thermal & Specialized Solutions segment saw revenues of $466 million, a 3% year-over-year increase, but fell short of the estimate of $479.2 million, with net sales growth driven by a 10% increase in volume, slightly offset by a 6% price decline [4]. - Revenues in the Advanced Performance Materials unit amounted to $294 million, a decline of approximately 3% year-over-year, yet beating the estimate of $289.4 million, with a 1% drop in volume and a 2% currency headwind [5]. Cash Flow and Capital Expenditures - Cash used by operating activities in Q1 2025 was $112 million, down from $290 million in the prior-year quarter, while capital expenditures were $84 million compared to $102 million in the previous year [6]. - The company reduced its dividend by 65% to $0.0875 per share to align with its capital allocation strategy [6]. Outlook - The company anticipates consolidated net sales to increase in the low to mid-teens sequentially in Q2, with adjusted EBITDA expected to rise by 40% to 45% [7]. - Full-year 2025 adjusted EBITDA is projected to be between $825 million and $950 million, with capital expenditures expected to range from $225 million to $275 million [7]. Stock Performance - Chemours shares have declined by 61.4% over the past year, compared to a 28.3% decline in the industry [8].

The Chemours Company (CC) Q1 2025 Earnings Call May 07, 2025 08:00 AM ET Company Participants Brandon Ontjes - Vice President of FP&A and Investor RelationsDenise Dignam - President & CEOShane Hostetter - SVP & CFOJohn Roberts - Managing DirectorJosh Spector - Executive Director Conference Call Participants John McNulty - MD - Chemicals AnalystPeter Osterland - Equity Research AnalystNone - AnalystLaurence Alexander - AnalystArun Viswanathan - Senior Equity AnalystDuffy Fischer - AnalystMichael Leithead - A ...

The Chemours Company (CC) Q1 2025 Earnings Call May 07, 2025 08:00 AM ET Speaker0 Good morning. My name is Michelle, I will be your conference operator today. I would like to welcome everyone to the Chemours Company First Quarter and Full Year twenty twenty five Results Conference Call. Currently, all participants are in a listen only mode. A question and answer session will follow the conclusion of the prepared remarks. I would like to remind everyone that this conference call is being recorded. I would no ...

Industry Overview - The chemicals industry has faced significant challenges over the past year, including weak industrial demand, a slowdown in China, and chronic excess supply [1] - These factors have resulted in weak pricing and slow volumes within the industry [1] Company Specifics - Chemours (NYSE: CC) is mentioned as being affected by the overall industry conditions, although specific performance metrics for Chemours are not detailed in the provided text [1]

For the quarter ended March 2025, Chemours (CC) reported revenue of $1.37 billion, up 1.3% over the same period last year. EPS came in at $0.13, compared to $0.32 in the year-ago quarter.The reported revenue represents a surprise of +0.94% over the Zacks Consensus Estimate of $1.36 billion. With the consensus EPS estimate being $0.19, the EPS surprise was -31.58%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectatio ...

Group 1: Earnings Performance - Chemours reported quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.19 per share, and down from $0.32 per share a year ago, representing an earnings surprise of -31.58% [1] - The company posted revenues of $1.37 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.94%, compared to year-ago revenues of $1.35 billion [2] - Over the last four quarters, Chemours has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Group 2: Stock Performance and Outlook - Chemours shares have lost about 28.4% since the beginning of the year, while the S&P 500 has declined by -3.9% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is $0.57 on $1.59 billion in revenues, and $1.81 on $5.89 billion in revenues for the current fiscal year [7] Group 3: Industry Context - The Zacks Industry Rank indicates that the Chemical - Diversified sector is currently in the bottom 18% of over 250 Zacks industries, suggesting potential challenges for stocks in this category [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The current estimate revisions trend for Chemours is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]

2 Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "est ...